Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2026-01-01 @ 11:24 AM
Study NCT ID:
NCT05576532
Status:
UNKNOWN
Last Update Posted:
2023-06-28
First Post:
2022-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia
Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SHXYXY-2022-VEN-T-LBL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None